Anti-GARP can reduce Treg-mediated suppression; Endoglin blockade decreases Treg infiltration and augments PD-1 inhibitor efficacy; CCR8+ Tregs are major immunosuppressive cells in CRC; anti-CCR8 therapy restores Th and CD8+ T cell function. This evidence concerns the gene LRRC32 and colorectal carcinoma.